| Product NDC: | 0023-3513 |
| Proprietary Name: | SANCTURA |
| Non Proprietary Name: | trospium chloride |
| Active Ingredient(s): | 20 mg/1 & nbsp; trospium chloride |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 0023-3513 |
| Labeler Name: | Allergan, Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA021595 |
| Marketing Category: | NDA |
| Start Marketing Date: | 20071201 |
| Package NDC: | 0023-3513-60 |
| Package Description: | 60 TABLET in 1 BOTTLE, PLASTIC (0023-3513-60) |
| NDC Code | 0023-3513-60 |
| Proprietary Name | SANCTURA |
| Package Description | 60 TABLET in 1 BOTTLE, PLASTIC (0023-3513-60) |
| Product NDC | 0023-3513 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | trospium chloride |
| Dosage Form Name | TABLET |
| Route Name | ORAL |
| Start Marketing Date | 20071201 |
| Marketing Category Name | NDA |
| Labeler Name | Allergan, Inc. |
| Substance Name | TROSPIUM CHLORIDE |
| Strength Number | 20 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Cholinergic Muscarinic Antagonist [EPC],Cholinergic Muscarinic Antagonists [MoA] |